Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT06866795 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer

Interventions

DRUG: GT-220F capsule

Sponsor

Geode Therapeutics Inc.